Korean J Urol Oncol.  2019 Apr;17(1):7-21. 10.22465/kjuo.2019.17.1.7.

The Treatments for Low-Risk Prostate Cancer

Affiliations
  • 1Department of Urology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
  • 2Center for Urological Cancer, National Cancer Center, Goyang, Korea.
  • 3Department of Urology, National Police Hospital, Seoul, Korea.
  • 4Department of Urology, Myongji Hospital, Goyang, Korea.
  • 5National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
  • 6Department of Urology, Inje University Seoul Paik Hospital, Seoul, Korea. yeoluvk@gmail.com

Abstract

Recently, the prevalence of prostate cancer has been increased with the screening of prostate-specific antigen and the increase in the elderly population. In particular, the diagnosis of the low-risk prostate cancer has increased greatly, and social interest for overtreatment has been heightened in Korea. Therefore, this review aimed to provide evidence-based treatment guidelines in low-risk prostate cancer based on Korean population. The literature provides evidence on treatment options, such as watchful waiting, active surveillance, radical prostatectomy, and radiation therapy according to the life expectancy of patients with low-risk prostate cancer. Furthermore, this review provides information on the efficacy of pelvic lymph node dissection and adjuvant radiation therapy during/after radical prostatectomy in low-risk prostate cancer.

Keyword

Prostatic neoplasms; Treatment-related cancers; Evidence-based medicine

MeSH Terms

Aged
Diagnosis
Evidence-Based Medicine
Humans
Korea
Life Expectancy
Lymph Node Excision
Mass Screening
Medical Overuse
Neoplasms, Second Primary
Prevalence
Prostate*
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms*
Watchful Waiting
Prostate-Specific Antigen
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr